Weston Inc. Builds State of the Art Healthcare Facility in Euclid, Ohio
Cleveland based Commercial and industrial real estate company Weston Inc. has been selected to develop a new state of the art facility for a nationally recognized healthcare company. Fresenius Medical Care North America, (FMCNA), based in Boston, is a major provider of kidney dialysis services and renal care products. Providing dialysis care services, education and support for Chronic Kidney Disease, Fresenius also manufactures and distributes a variety of dialysis products and equipment, including dialysis machines, dialyzers and other dialysis-related supplies. FMCNA is a wholly owned subsidiary of Fresenius Medical Care AG & Co. KGaA, located in Bad Homburg, Germany. The building will be leased and managed by Weston.
Weston Development Company is purchasing 3.11 acres of land from the City of Euclid, and has hired The M.E. Osborne Company as the design/build contractor for the project. The 10,750 square foot building will be built to Fresenius’ specifications and house over 25 employees. The ground-breaking is tentatively scheduled for November 2010 “We are thrilled to be chosen to deliver this project for Fresenius”, said Mark Horton who will spearhead the project for Weston. “Our experience in healthcare development, coupled with the expertise of the M.E. Osborne Company, will make this an exciting addition for the City of Euclid.”
“Mark Horton’s past experience as Project Manager on healthcare facility projects such as Summa Health System’s Cardio/Pulmonary Center in Akron, Ohio made choosing Weston Development a natural choice for us”, said Bill Popken, Senior RE manager for Fresenius. “We have every confidence that our newest facility will be exactly as we envisioned.”
About Weston
Weston owns and manages a real estate portfolio of more than 12 million square feet in 10 states. Established in 1972, the company today has offices in Cleveland, Ohio, and Louisville, Kentucky. They maintain strong relations with over 450 tenants nationwide.